Email Email Print Print
Clip Clip & File

Only on :: Latest News

May 14, 2013

Evonik Industries and OPX Biotechnologies to jointly develop bio-based chemicals

Dorothy Lozowski

Evonik Industries AG (Essen; and OPX Biotechnologies, Inc. (OPXBio; Boulder, Colo.; have entered into an agreement to jointly develop certain bio-based specialty chemicals. The joint development agreement was signed May 3, 2013, and calls for OPXBio to use its proprietary EDGE (efficiently directed genome engineering) technology to develop the bio-processes.

Add a Comment


Please enter the letters or numbers you see in the image. (refresh)

Related Stories

LinkedIn Groups

Our LinkedIn group is now over 33,000 members strong!

  1. Join other CPI professionals from all over the globe and share best practices, expertise, concerns and more.
  2. Provide feedback to Chemical Engineering Editors

Current members represent Worley Parsons, DuPont, SABIC, Fluor, Air Products, LyondellBasell, Nalco, Dow Chemical, Dow Corning, BASF, Jacobs Engineering, ExxonMobil, Shell, Chevron and more.

Join Now

We also offer the following subgroup for more targeted discussions:

Search the Buyers' Guide

Plant Cost Index

Facts at Your Fingertips (archive)

Ask the Experts

Back Issues
To access this area, please log in or create an account.
Forgot your password?
Request it now.
Live chat by BoldChat